Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
Cash Flows From Operating Activities | |||||
Net Income | 5,687,000 | 5,309,000 | 5,953,000 | 5,144,000 | 1,774,000 |
Depreciation Amortization | 1,765,000 | 1,501,000 | 1,189,000 | 836,000 | 786,000 |
Income taxes - deferred | -1,517,000 | 1,242,000 | N/A | N/A | N/A |
Accounts receivable | -591,000 | -391,000 | -71,000 | -1,076,000 | -172,000 |
Accounts payable and accrued liabilities | 734,000 | 425,000 | -1,187,000 | 1,503,000 | -193,000 |
Other Working Capital | 467,000 | 93,000 | -1,299,000 | 993,000 | -354,000 |
Other Operating Activity | 6,882,000 | 1,781,000 | 2,456,000 | 135,000 | 1,708,000 |
Operating Cash Flow | $13,427,000 | $9,960,000 | $7,041,000 | $7,535,000 | $3,549,000 |
Cash Flows From Investing Activities | |||||
PPE Investments | -638,000 | -529,000 | -479,000 | -532,000 | -612,000 |
Net Acquisitions | -736,000 | -308,000 | -2,757,000 | -12,452,000 | -622,000 |
Purchase Of Investment | -1,792,000 | -2,230,000 | -5,315,000 | -851,000 | -1,169,000 |
Sale Of Investment | 2,160,000 | 2,793,000 | 2,359,000 | 899,000 | 1,477,000 |
Other Investing Activity | 0 | 0 | 118,000 | 0 | 0 |
Investing Cash Flow | $-1,006,000 | $-274,000 | $-6,074,000 | $-12,936,000 | $-926,000 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | 3,301,000 | 23,000 | -23,000 | -19,000 | 12,000 |
Debt Issued | 5,963,000 | 0 | 11,627,000 | 20,660,000 | 0 |
Debt Repayment | -6,035,000 | -25,000 | -6,010,000 | -4,018,000 | -17,000 |
Common Stock Issued | 73,000 | 254,000 | 268,000 | 155,000 | 232,000 |
Common Stock Repurchased | -12,014,000 | -1,410,000 | -6,033,000 | -7,586,000 | -665,000 |
Dividend Paid | -5,580,000 | -4,107,000 | -3,717,000 | -3,294,000 | -2,661,000 |
Other Financing Activity | -104,000 | -247,000 | -40,000 | -146,000 | -194,000 |
Financing Cash Flow | $-14,396,000 | $-5,512,000 | $-3,928,000 | $5,752,000 | $-3,293,000 |
Exchange Rate Effect | -39,000 | 29,000 | -338,000 | -300,000 | -577,000 |
Beginning Cash Position | 9,303,000 | 5,100,000 | 8,399,000 | 8,348,000 | 9,595,000 |
End Cash Position | 7,289,000 | 9,303,000 | 5,100,000 | 8,399,000 | 8,348,000 |
Net Cash Flow | $-2,014,000 | $4,203,000 | $-3,299,000 | $51,000 | $-1,247,000 |
Free Cash Flow | |||||
Operating Cash Flow | 13,427,000 | 9,960,000 | 7,041,000 | 7,535,000 | 3,549,000 |
Capital Expenditure | -638,000 | -529,000 | -479,000 | -532,000 | -612,000 |
Free Cash Flow | 12,789,000 | 9,431,000 | 6,562,000 | 7,003,000 | 2,937,000 |